NASDAQ · Medical - Healthcare Information Services

HCTI (HCTI) Stock

$1.09 +6.86% NASDAQ: HCTI Healthcare

Valuation

MetricValue
Price$1.09
Market Cap$1.26M
P/E Ratio0.01
P/B Ratio0.15
P/S Ratio0.13
EPS (TTM)$-13.29
52-Week High$1299.78
52-Week Low$1.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-45.61%
ROA-16.33%
ROCE-100.00%
Gross Margin15.69%
Operating Margin-59.94%
Net Margin-69.72%
Debt/Equity0.21
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$35.0M$46.0M$33.0M$12.0M$14.0M
Operating Profit$-5.0M$-16.0M$-8.0M$-5.0M$-10.0M
Net Profit$-6.0M$-14.0M$-9.0M$-6.0M$-9.0M
EPS$-30202.01$-57997.93$-31051.57$-16895.02$-15308.56
Op Margin-15.2%-35.6%-23.2%-40.6%-70.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$25.0M$13.0M$7.0M$2.0M$23.0M
Total Liabilities$8.0M$7.0M$8.0M$7.0M$13.0M
Cash$2.0M$1.0M$1.0M$0$8.0M
Borrowings$3.0M$3.0M$4.0M$3.0M$11.0M

Latest News

WallachBeth Capital Announces Closing of Healthcare Triangle, Inc. Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of Approximately $3.6 Million PR Newswire · Jun 12, 2026 Healthcare Triangle Closes Private Placement of Original Issue Discount Senior Convertible Promissory Notes MT Newswires · Jun 12, 2026 Healthcare Triangle, Inc. Announces Closing of Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of Approximately $3.6 Million CNW Group · Jun 12, 2026 HCTI Reports Rapid Revenue Growth Zacks Small Cap Research · May 14, 2026 Healthcare Triangle Reports 627% Increase in Gross Profit and 166% Increase in Revenue for Q1 2026 PR Newswire · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-5.0M$-2.0M$-1.0M$-17.0M
Investing Cash Flow$-11.0M$-2.0M$0$0$-2.0M
Financing Cash Flow$0$0$0$1.0M$-1.0M
Net Cash Flow$0$0$0$-1.0M$8.0M
Free Cash Flow$-10.0M$-6.0M$-2.0M$-1.0M$-17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-3.40
FCF Yield-978.58%
Quick Ratio0.90
Interest Coverage-10.00
Return 1Y-99.40%
Return 3Y-100.00%
Return 5Y—

Ownership

Insiders Held0.01%
Institutions Held5.55%
Institutions Float Held5.55%
Institutional HolderSharesReport Date
UBS Group AG40,7152026-03-31
Morgan Stanley20,4702026-03-31
Virtu Financial LLC14,6162026-03-31
Geode Capital Management, LLC12,5952026-03-31
Bank of Montreal /CAN/10,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADGM $0.38 +1.60% -0.56 $8.45M 0.00%
ADTX $0.01 -77.22% -0.01 $318 0.00%
AIMD $1.49 -3.87% -0.43 $10.97M 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
COCH $0.67 +1.71% -0.74 $14.02M 0.00%

About HCTI

HCTI is led by CEO Lakshmanan Kannappan, employs 36 people, headquartered in US, publicly traded since 2021.

HCTI stock trades at $1.09 with a market capitalization of $1.26M. The stock is valued at a price-to-earnings (P/E) ratio of 0.01, price-to-book of 0.15, price-to-sales of 0.13. Over the past 52 weeks the stock has ranged between $1.09 and $1299.78, and currently trades 99.9% below its 52-week high.

On profitability, HCTI generates a return on equity (ROE) of -45.61%, return on capital employed of -100.00%, an operating margin of -59.94%, a net profit margin of -69.72%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides